Targeting plasma kallikrein with a novel bicyclic peptide inhibitor (THR-149) reduces retinal thickening in a diabetic rat model

Tine Van Bergen. Targeting plasma kallikrein with a novel bicyclic peptide inhibitor (THR-149) reduces retinal thickening in a diabetic rat model

Publication date:
November, 2020
Attachment:
PDF icon OXUR EASDEC2020_THR149 rat STZ_final_.pdf

Oxurion NV

Gaston Geenslaan 1
B-3001 Leuven
Belgium

© 2023 Oxurion NV. All rights reserved.
Linkedin-in